Literature DB >> 36096795

Retraction Note: MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.

Zhikui Liu1, Yufeng Wang1, Changwei Dou2, Liankang Sun1, Qing Li1, Liang Wang1, Qiuran Xu3, Wei Yang1, Qingguang Liu4, Kangsheng Tu5.   

Abstract

Entities:  

Year:  2022        PMID: 36096795      PMCID: PMC9469534          DOI: 10.1186/s13046-022-02487-y

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


× No keyword cloud information.
Retraction Note: J Exp Clin Cancer Res 37, 49 (2018) https://doi.org/10.1186/s13046-018-0717-3 The Editor-in-Chief has retracted this article at the corresponding author's request. After publication, the authors became aware that data from other projects were included in the figures, resulting in image overlap between this article and previous publications from other authors. Specifically: Fig. 3a appears to overlap with Fig. 4a in [1]; Fig. 7g Cyclin D1 lanes 3 and 4 appear highly similar to Fig. 9d E-cadherin lanes 2 and 3 in [2]. Additionally, parts of images in Figs. 2d, 3a, 7g and 8f have subsequently been used in [3-7]. The authors have therefore lost confidence in the data presented in this article. Author Kangsheng Tu has stated on behalf of all co-authors that they agree to this retraction.
  7 in total

1.  MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BCL9.

Authors:  Bowen Yao; Yazhao Li; Liang Wang; Tianxiang Chen; Yongshen Niu; Qingguang Liu; Zhikui Liu
Journal:  Artif Cells Nanomed Biotechnol       Date:  2019-12       Impact factor: 5.678

2.  LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma.

Authors:  Nan Yang; Jinqiu Chen; Hui Zhang; Xiaman Wang; Huan Yao; Yue Peng; Wanggang Zhang
Journal:  Cell Death Dis       Date:  2017-08-10       Impact factor: 8.469

3.  MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.

Authors:  Qiuran Xu; Xin Liu; Zhikui Liu; Zhenyu Zhou; Yufeng Wang; Jianfeng Tu; Lijie Li; Hangxing Bao; Liu Yang; Kangsheng Tu
Journal:  Mol Cancer       Date:  2017-06-12       Impact factor: 27.401

4.  CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway.

Authors:  Nan Yang; Tianxiang Chen; Liang Wang; Runkun Liu; Yongshen Niu; Liankang Sun; Bowen Yao; Yufeng Wang; Wei Yang; Qingguang Liu; Kangsheng Tu; Zhikui Liu
Journal:  Theranostics       Date:  2020-04-27       Impact factor: 11.556

5.  Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway.

Authors:  Zhikui Liu; Huanye Mo; Liankang Sun; Liang Wang; Tianxiang Chen; Bowen Yao; Runkun Liu; Yongshen Niu; Kangsheng Tu; Qiuran Xu; Nan Yang
Journal:  Cancer Sci       Date:  2020-09-23       Impact factor: 6.716

6.  KLF10 inhibits cell growth by regulating PTTG1 in multiple myeloma under the regulation of microRNA-106b-5p.

Authors:  Mimi Zhou; Jinqiu Chen; Hui Zhang; Hailing Liu; Huan Yao; Xiaman Wang; Wanggang Zhang; Yingren Zhao; Nan Yang
Journal:  Int J Biol Sci       Date:  2020-05-15       Impact factor: 10.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.